Polymorph of echinocandin antifungal agent
The present invention relates to crystalline polymorphs of an echinocandin antifungal agent and novel methods for their preparation.
1. A solid crystalline form of compound 1 acetate having an X-ray powder diffraction (XRPD) pattern comprising
angles 2θ (°) of 7.1±0.2, 9.2±0.2, and 13.7±0.2.
2. A solid crystalline form of compound 1 acetate having an X-ray powder diffraction (XRPD) pattern comprising angles 2θ (°) of 7.1±0.2, 9.2±0.2, and 13.7±0.2 and one or more angles 2θ(°) selected from the group consisting of 7.8±0.2, 8.3±0.2, 10.5±0.2, 14.9±0.2, 16.6±0.2, 17.6±0.2, 19.4±0.2, 20.5±0.2, 22.7±0.2, and 27.5±0.2.
3. A solid crystalline form of compound 1 acetate having an X-ray powder diffraction (XRPD) pattern comprising angles 2θ (°) of 6.8±0.2, 7.4±0.2, 8.2±0.2, and 9.5±0.2 and one or more angles 2θ (°) selected from the group consisting of 10.1±0.2, 13.5±0.2, 15.0±0.2, 20.0±0.2, 20.3±0.2, and 21.9±0.2.
4. A solid crystalline form of compound 1 acetate having an X-ray powder diffraction (XRPD) pattern comprising angles 2θ (°) of 3.2±0.2 and 6.2±0.2 and one or more angles 2θ (°) selected from the group consisting of 9.3±0.2, 12.3±0.2, 15.5±0.2, 17.9±0.2, 18.5±0.2, 19.4±0.2, and 21.6±0.2.
5. A solid crystalline form of compound 1 acetate having an X-ray powder diffraction (XRPD) pattern comprising angles 2θ (°) of 6.0±0.2 and 8.7±0.2 and one or more angles 2θ (°) selected from the group consisting of 10.6±0.2, 14.7±0.2, 14.9±0.2, 15.3±0.2, 15.5±0.2, 17.2±0.2, 18.9±0.2, 19.7±0.2, 20.0±0.2, 21.5±0.2, 21.6±0.2, 21.8±0.2, 22.4±0.2, and 23.7±0.2.